• Home
  • News
  • Portfolio News
  • TetraGenetics Announces Discovery of Functional Antibodies Against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference

TetraGenetics Announces Discovery of Functional Antibodies Against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference

15Dec

TetraGenetics Announces Discovery of Functional Antibodies Against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference

Portfolio News
TetraGenetics, a biopharmaceutical company developing novel antibody therapeutics for ion-channel mediated disorders, announced today that they will be presenting news of the discovery of functional antibodies against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference taking place Dec 14th – 16th. Read more >>

Share this post

Related Posts

12Dec

Born blind, this Columbia student sees a brighter future thanks to visionary glasses Read more here: https://www.thestate.com/news/local/article222567185.html#storylink=cpy

The first time Tori Diamond saw the features of her mother’s face, she saw tears. Read more >> read more
26Jun

NEO has played critical role in success of Boston-based medical device maker

When Boston-based medical device company Myomo rang the bell of the New York Stock Exchange on June 16, it was... read more
29Dec

Midland’s New Spaceport Aims to Make Space Travel Accessible to All

Drive down a windy, muddy road, hidden on the backside of Midland airport’s southernmost tarmac, and you’ll find a shiny... read more
05Sep

Pixability Announces Launch Of Video Creative Decisioning Engine

Patented AI-Driven Technology Maximizes Video Creative Effectiveness on YouTube. Read more >> read more
21Mar

Regroup Mass Notification Partners with USGS to Bring Earthquake Early Warnings to the West Coast

Regroup Mass Notification, industry leading provider of emergency and day-to-day mass communication solutions, today announced a finalized partnership with the... read more
09Feb

EarthGrid, PBC Wins ‘Most Fundable Company’ Award from Pepperdine Graziadio Business School

EarthGrid, PBC is excited to announce that it won Platinum recognition — the highest honor — on the Pepperdine Graziadio... read more
11Mar

Ergoresearch becomes the reference for the evaluation of knee pain in Quebec

With the support of Ergoresearch, Équilibre—the largest network of orthotists in Quebec , announces the adoption of the latest cutting-edge... read more
23Dec

Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands

Akston Biosciences, Inc. a developer of new classes of biologic therapeutics, today announced positive data from the Phase II clinical... read more
28Feb

Using GSA Federal Contracts to Improve Campus Safety and Security

Regroup Mass Notification, the award-winning leader in emergency and day-to-day mass communication technology, today announced that it is joining forces... read more
08Jul

Pittsburgh biotech company wins funding for Covid-19 drug

Pittsburgh biotech company CytoAgents has received $250,000 from the Richard King Mellon Foundation to help develop its drug candidate to... read more